Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside.
about
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?Present and future of personalized medicine in adult genitourinary tumors.Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma.Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.Predictive role of tissue-based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma.Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis.Immunotherapy in renal cell carcinoma: latest evidence and clinical implications.The Identification of Immunological Biomarkers in Kidney Cancers
P2860
Q35083485-5ED86974-AF39-417E-B5F6-81FBD2A1C37CQ38465841-3D5603A8-F441-42D7-BA12-48C556BA6197Q38543085-46A67F88-5983-4FCD-BB51-F7531BC8143CQ41624982-6A962D6A-CE37-4835-870E-9149D3F508A3Q41729849-FC223BED-099E-4B30-8303-CD7402F91AF7Q43725656-0A5F19FC-2292-42E3-B731-86065DC2E0D6Q47136435-7D9518B9-A7B1-44D9-AC25-9F5EACB1C941Q55101776-E14C63B5-142C-49CB-BC12-93E75A9A8C62Q59132089-A3BC5FE8-0EBF-4881-B533-562D8F7A7638
P2860
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Heterogeneous drug target expr ...... estions from bench to bedside.
@en
type
label
Heterogeneous drug target expr ...... estions from bench to bedside.
@en
prefLabel
Heterogeneous drug target expr ...... estions from bench to bedside.
@en
P2093
P2860
P50
P1476
Heterogeneous drug target expr ...... estions from bench to bedside.
@en
P2093
Francesco Massari
Luciano Burattini
Roberto Iacovelli
P2860
P2888
P304
P356
10.1007/S10555-013-9453-5
P50
P577
2014-03-01T00:00:00Z
P5875
P6179
1032374284